8-K 1 a08-1674_28k.htm 8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  January 10, 2008

 

Cellu Tissue Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

333-118829

06-1346495

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

 

1855 Lockeway Drive
Suite 501
Alpharetta, Georgia



30004

(Address of principal executive offices)

(Zip Code)

 

 

 

Registrant’s telephone number, including area code   (678) 393-2651

 

 

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 


 

Item 2.02  RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

Cellu Tissue Holdings, Inc. issued a press release today announcing third quarter earnings for the quarter ended November 29, 2007.  The press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

 

The information in this Form 8-K, including the accompanying exhibit, is being furnished hereunder and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01  FINANCIAL STATEMENTS AND EXHIBITS

 

The following is being furnished as an exhibit to this Current Report on Form 8-K:

 

(d) Exhibits

        99.1      Release, dated January 10, 2008, “Cellu Tissue Holdings, Inc. Announces Third Quarter 2008 Results, “ furnished pursuant to Item 2.02

 

 

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Cellu Tissue Holdings, Inc.

 

 

 

 

(Registrant)

 

 

 

 

 

 

 

Date: January 10, 2008

 

 

By:

 /s/ David J. Morris

 

 

 

 

 

Mr. David J. Morris

 

 

 

 

 

Senior Vice President, Finance and Chief Financial Officer

 

 

 

 

 

2


 

EXHIBIT INDEX

 

 

99.1      Release, dated January 10, 2008 “Cellu Tissue Holdings, Inc. Announces Third Quarter 2008 Results”

 

 

 

 

 

 

 

 

 

3